Literature DB >> 19188810

Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study.

Nadia Danon-Hersch1, Pedro Marques-Vidal, Pascal Bovet, Arnaud Chiolero, Fred Paccaud, Alain Pécoud, Daniel Hayoz, Vincent Mooser, Gérard Waeber, Peter Vollenweider.   

Abstract

BACKGROUND: This study is aimed to assess the prevalence of awareness, treatment and control of high blood pressure (HBP) and associated factors in a Swiss city.
DESIGN: Population-based cross-sectional study of 6182 participants (52.5% women) aged 35-75 years living in Lausanne, Switzerland.
METHODS: HBP was defined as blood pressure >/=140/90 mmHg or current antihypertensive medication.
RESULTS: The overall prevalence of HBP was 36% (95% confidence interval: 35-38%). Among participants with HBP, 63% were aware of it. Among participants aware of HBP, 78% were treated, and among those treated, 48% were controlled (BP <140/90 mmHg). In multivariate analysis, HBP prevalence was associated with older age, male sex, low educational level, high alcohol intake, awareness of diabetes or dyslipidaemia, obesity and parental history of myocardial infarction. HBP awareness was associated with older age, female sex, awareness of diabetes or dyslipidaemia, obesity and parental history of myocardial infarction. HBP control was associated with younger age, higher educational level and no alcohol intake. Alone or in combination, sartans were the most often prescribed antihypertensive medication category (41%), followed by diuretics, beta-blockers, angiotensin converting enzyme inhibitors and calcium channel blockers. Only 31% of participants treated for HBP were taking >/=2 antihypertensive medications.
CONCLUSION: Although more than half of all participants with HBP were aware and more than three-quarters of them received a pharmacological treatment, less than half of those treated were adequately controlled.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188810     DOI: 10.1097/HJR.0b013e32831e9511

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  26 in total

1.  Effectiveness of nurse-delivered cardiovascular risk management in primary care: a randomised trial.

Authors:  Helene R Voogdt-Pruis; George H M I Beusmans; Anton P M Gorgels; Arnold D M Kester; Jan W Van Ree
Journal:  Br J Gen Pract       Date:  2010-01       Impact factor: 5.386

2.  Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus.

Authors:  Luísa Lima Castro; Cristina Costa Duarte Lanna; Antônio Luiz Pinho Ribeiro; Rosa Weiss Telles
Journal:  Clin Rheumatol       Date:  2018-06-12       Impact factor: 2.980

3.  Diagnosed hypertension in Canada: incidence, prevalence and associated mortality.

Authors:  Cynthia Robitaille; Sulan Dai; Chris Waters; Lidia Loukine; Christina Bancej; Susan Quach; Joellyn Ellison; Norman Campbell; Karen Tu; Kim Reimer; Robin Walker; Mark Smith; Claudia Blais; Hude Quan
Journal:  CMAJ       Date:  2011-11-21       Impact factor: 8.262

4.  Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.

Authors:  Luísa Lima Castro; Cristina Costa Duarte Lanna; Mariana Pimenta Rocha; Antônio Luiz Pinho Ribeiro; Rosa Weiss Telles
Journal:  Rheumatol Int       Date:  2018-06-15       Impact factor: 2.631

5.  Influence of dyslipidemia in control of arterial hypertension among type-2 diabetics in the western region of the Republic of Macedonia.

Authors:  Ylber Jani; Amet Kamberi; Fatmir Ferati; Atila Rexhepi; Bekim Pocesta; Nikola Orovcanec; Dali Lala; Gafur Polisi; Mair Iseni; Arben Mirto; Agim Zeqiri
Journal:  Am J Cardiovasc Dis       Date:  2014-06-28

6.  Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007.

Authors:  Daniel Estoppey; Fred Paccaud; Peter Vollenweider; Pedro Marques-Vidal
Journal:  BMC Public Health       Date:  2011-02-18       Impact factor: 3.295

7.  Hypertension prevalence, awareness, treatment and control, and associated factors: results from a national survey, jordan.

Authors:  H Y Jaddou; A M Batieha; Y S Khader; A H Kanaan; M S El-Khateeb; K M Ajlouni
Journal:  Int J Hypertens       Date:  2011-12-01       Impact factor: 2.420

8.  Regional differences in self-reported screening, prevalence and management of cardiovascular risk factors in Switzerland.

Authors:  Pedro Marques-Vidal; Fred Paccaud
Journal:  BMC Public Health       Date:  2012-03-28       Impact factor: 3.295

9.  Age and gender differences in the social patterning of cardiovascular risk factors in Switzerland: the CoLaus study.

Authors:  Silvia Stringhini; Brenda Spencer; Pedro Marques-Vidal; Gerard Waeber; Peter Vollenweider; Fred Paccaud; Pascal Bovet
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

10.  Level of unawareness and management of diabetes, hypertension, and dyslipidemia among adults in Luxembourg: findings from ORISCAV-LUX study.

Authors:  Ala'a Alkerwi; Sybil Pagny; Marie-Lise Lair; Charles Delagardelle; Jean Beissel
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.